The new generation of successful remedies against obesity and diabetes was recommended on Tuesday, September 9, for the first time by the World Health Organization (WHO), while demanding cheaper generic versions for developing countries to be made available. The who added Semaglutide – the active ingredient of the Ozempic and Wegovy of the Danish pharmaceutical industry Novo Nordisk – Doulaglutidis and Liglutidis, as well as Tirzepatide – used in Eli Lilly’s Mounjaro formulation – to his two -year -olds. Based on the body’s data, more than 3.7 million people died in 2021 from diseases associated with obesity -more than those who died of basic, deadly infectious diseases, malaria, tuberculosis and AIDS together. New treatments for diabetes and obesity enhance the action of a hormone that affects the secretion of insulin (GLP-1) and in general the feeling of satiety. Initially these preparations were developed for diabetes, but have shown remarkable results in loss […]
Source: News Beast

With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.